An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Hearing Loss Linked to Lower Income in Young Adults
Hearing loss, as well as tinnitus, has been correlated with socioeconomic factors such as reduced income and unemployment (Nadler, 2023). This correlation is even more impactful…
Tympanoplasty in Children: A Retrospective Study
The purpose of a tympanoplasty is to repair a hole in a tympanic membrane (TM). An important functional outcome of this surgery is to improve…
Sounds That Thrill or Chill
As we are about to enter the fall and are getting closer to Halloween, some of you may be looking for some thrilling experiences. If…